In the specialized field of molecular delivery and biochemical research, the transferrin receptor targeting peptide has emerged as a cornerstone for site-specific interaction studies. As an enthusiast who foll by ZR Crook·2020·Cited by 41—A drug-like cystine-densepeptidethat bindstransferrin receptorwas identified Targetingthetransferrin receptorfor brain drug delivery, Prog. Neurobiol Read more ows the latest in peptide synthesis and bio-conjugation, I have spent significant time examining how these ligands interact with the transferrin receptor (TfR), a cell membrane-associated glycoprotein that plays a critical role in iron homeostasis and cell growth.
The Science Behind TfR Binding
The transferrin receptor is highly expressed in various tissues, making it an ideal target for experimental delivery systems. When we discuss a transferrin receptor targeting peptide, we are looking at short, synthetic amino acid sequences designed to dock with the receptor. A significant advantage of these peptides is their ability to home in on specific sites wit Lipid vesicles containing transferrin receptor binding hout necessarily competing with natural transferrin for the primary binding pocket.
During my exploration of the literature, I discovered that specific sequences like HAIYPRH, THRPPMWSPVWP, and SPRPRHTLRLSL have become industry standards for research. These sequences are frequently utilized because they can enable transcytosis across an endothelial layer, which is a fundamental requirement for traversing the blood-brain barrier (BBB).
Key Rese Dec 20, 2001—Interestingly,transferrindid not compete with either of these sequences forreceptorbinding, suggesting that thesepeptidesbind a site on Read more arch Entities and Variations
When evaluating these compounds, it is crucial to recognize the specific variants available to researchers:
* TfR-T12: Perhaps the most widely recognized in this category, TfR-T12 is a BBB-penetrated transferrin receptor (TfR) binding peptide that demonstrates binding affinity in the nanomolar range.
* T7 Peptide: Often used in gene delivery vectors, the T7 segment is a robust tool for binding receptors effectively.
* D-T7: A stabilized retro-inverso version of the T7 sequence, designed to provide superior serum stability.
These tools are not merely static; they are dynamic instruments. For instance, TfR-T12 has been successfully integrated into lipid vesicles to investigate the delivery of cargo into cells overexpressing transferrin receptors, such as those found in specific malignant tissue models.
Applications in Experimental Delivery
The primary utility of these molecules lies in their ability to act as a receptor-targeting agent, like transferrin. When a researcher employs a TfR targeting peptide, they are essentially building a molecular "ferry." This peptide can be conjugated to various payloads, and because it can traffic bioactive molecules across the blood brain barrier, it is a subject of intense investigation for those studying neuro-focused delivery mechanisms.
Furthermore, the TfR1-binding peptide conjugation strategy has proven versatile. Whether designing a drug targeting vector with the transferrin receptor TfR or creating a human transferrin receptor peptide for blotting applications, the accuracy of these binders is paramount.
Practical Considerations for Researchers
If you are looking to incorporate the A TfR-binding cystine-dense peptide promotes blood-brain se into your work, consider the following insights gathered from community data:
1. Specificity: Always verify the binding affinity. Sequences like Pep-1, Pep-2, Pep-10, and Pep-L offer different binding profiles depending on whether the target is human or mouse receptors.
2. Structural Stability: Incorporating D-amino acids (like in D-T7) can significantly enhance the lifespan of the peptide in biological media.
3. Experimental Design: Remember that the transferrin receptor is a promising target in cancer therapy due to its density on rapidly dividing cells. Always ensure your targeting peptide is high-purity, as contaminan Jun 21, 2025—These findings supportTfR1-binding peptide conjugationas a promising strategy for CNS-targeted siRNA delivery.Read more ts can interfere with th 1 day ago—Introduction.tfr targeting peptiderefers to short peptide ligands engineered or selected to bind the transferrin receptor (TfR)—often TfR1 Read more e delicate binding kinetics required TfR Targeting Peptide - 1 mg for receptor-mediated uptake.
Whether your goal is to study the tfr targeting peptide f 1 day ago—Introduction.tfr targeting peptiderefers to short peptide ligands engineered or selected to bind the transferrin receptor (TfR)—often TfR1 Read more or basic biochemical characterization or to push the boundaries of how we target specific membrane proteins, the precision of these synthetic ligands remains unmatched. By focusing on the transferrin receptor as a gateway, we continue to unlock new methodologies for modular, site-specific molecular transport in a research setting.